drugset / Trial / NCT01785862

Ibuprofen Lozenge in Acute Sore Throat Pain

NCT01785862

Phase 3 Completed 427 enrolled Pierre Fabre Laboratories
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of repeated doses of a low dosage of oromucosal Ibuprofen form (lozenge) versus placebo in patients suffering from acute sore throat pain.

Timeline

Start
2013-02
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 25 mg Other

Indications